PFE,KMX Stock Price and Quote

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.13
Percentage change -0.50	%

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO SPY IVV VTV XLV VYM COWZ VHT DVY

Index	S&P 500	P/E	18.59	EPS (ttm)	1.38	Insider Own	0.18%	Shs Outstand	5.68B	Perf Week	1.06%
Market Cap	145.83B	Forward P/E	8.30	EPS next Y	3.09	Insider Trans	0.17%	Shs Float	5.67B	Perf Month	5.56%
Enterprise Value	190.92B	PEG	-	EPS next Q	0.57	Inst Own	67.00%	Short Float	1.97%	Perf Quarter	14.05%
Income	7.87B	P/S	2.33	EPS this Y	-3.65%	Inst Trans	0.94%	Short Ratio	2.57	Perf Half Y	-5.46%
Sales	62.46B	P/B	1.61	EPS next Y	3.09%	ROA	3.67%	Short Interest	111.91M	Perf YTD	-3.32%
Book/sh	15.89	P/C	8.42	EPS next 5Y	-0.18%	ROE	8.62%	52W High	31.54 -18.67%	Perf Year	-7.47%
Cash/sh	3.05	P/FCF	13.00	EPS past 3/5Y	-28.65% -13.25%	ROIC	5.32%	52W Low	20.92 22.64%	Perf 3Y	-51.37%
Dividend Est.	1.71 (6.65%)	EV/EBITDA	7.92	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	66.93%	Volatility	1.94% 1.65%	Perf 5Y	-21.57%
Dividend TTM	1.70 (6.63%)	EV/Sales	3.06	EPS Y/Y TTM	2770.58%	Oper. Margin	27.53%	ATR (14)	0.46	Perf 10Y	-18.89%
Dividend Ex-Date	Jul 25, 2025	Quick Ratio	0.96	Sales Y/Y TTM	13.38%	Profit Margin	12.59%	RSI (14)	68.10	Recom	2.44
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.26	EPS Q/Q	-5.13%	SMA20	3.74%	Beta	0.49	Target Price	28.21
Payout	119.94%	Debt/Eq	0.69	Sales Q/Q	-7.82%	SMA50	7.39%	Rel Volume	0.73	Prev Close	25.78
Employees	81000	LT Debt/Eq	0.64	Earnings	Aug 05 BMO	SMA200	-0.01%	Avg Volume	43.58M	Price	25.65
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	38.22% -1.47%	Trades		Volume	31,600,811	Change	-0.50%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Today 02:48AM	Pfizer (PFE) Reports XTANDI Shows Life-Extending Benefits (Insider Monkey)
Jul-12-25 09:36AM	FDA willing to trade faster drug reviews for lower prices, Bloomberg reports (TipRanks)
Jul-11-25 04:56PM	Big pharma's multiple looming patent cliffs: What to know (Yahoo Finance Video)
12:10PM	Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:58AM	MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients (Zacks)
10:05AM	Loading…
10:05AM	Adrenal Crisis Market Analysis and Forecast Report 2025-2035 with Competitive Benchmarking of Eton Pharmaceuticals, Antares Pharma, and Pfizer (GlobeNewswire)
07:27AM	Pfizer and Astellas Xtandi improves OS as combination therapy (Clinical Trials Arena)
04:21AM	Functional Dyspepsia Market Analysis and Forecast, 2025-2035, Competitive Analysis of AstraZeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong (GlobeNewswire)
04:19AM	Burns Market Analysis and Forecast Report 2025-2035 Featuring Pfizer, Perrigo, Kenvue Brands, 3M, Smith+Nephew, Molnlycke, Cardinal Health, Convatec, Haleon, Coloplast, DeRoyal Industries (GlobeNewswire)
04:07AM	Chlamydia Market Analysis and Forecast, 2025-2035 Featuring ActivBiotics, Bausch Health, Allergan, WCG Clinical, Hologic, Evofem, CRMI, Meridian Bioscience, Pfizer (GlobeNewswire)
04:01AM	Psoriatic Arthritis Market Report 2025-2035 \| Competitive Analysis of AbbVie, UCB, Pfizer, Johnson & Johnson, Eli Lilly and Co, Bristol-Myers Squibb, Affibody, Amgen, Boehringer Ingelheim, Sun Pharma (GlobeNewswire)
Jul-10-25 01:30PM	Wednesdays Unusual Options Activity Reveals 3 Standout Long Straddle Plays (Barchart)
09:55AM	Danon Disease Treatment Modality Market Analysis and Forecasts 2025-2035 \| Next-Gen Sequencing Speeds Up Danon Disease Diagnosis and Treatment Pathways (GlobeNewswire)
09:47AM	Alcohol Related Liver Disease Market Forecast, 2025-2035 \| Personalized Medicine Transforming ARLD Treatment Landscape (GlobeNewswire)
06:45AM	XTANDI Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence (Business Wire)
12:12PM	Loading…
Jul-09-25 12:12PM	Pfizer Earnings Preview: What to Expect (Barchart)
09:24AM	Merck Faces Multiple Challenges: Will It Steer Through Successfully? (Zacks)
09:11AM	JNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now? (Zacks)
06:35AM	Stocks to Watch Wednesday: Freeport-McMoRan, UnitedHealth, Novo Nordisk (The Wall Street Journal)
01:03AM	Companies Like Pfizer Inc (PFE) are Boosting the Cannabis Light Market (Insider Monkey)
Jul-08-25 05:45PM	Pfizer (PFE) Ascends While Market Falls: Some Facts to Note (Zacks)
04:20PM	Centivax Raises Oversubscribed $45 Million Series A Led by Future Ventures to Advance Universal Flu Vaccine into Clinic and Expand Universal Immunity Portfolio (PR Newswire)
04:01PM	Stock market today: Dow, S&P 500 slip as Trump stays firm on August tariff deadline, announces copper duties (Yahoo Finance)
02:27PM	Stock market today: Dow, S&P 500, Nasdaq steady as Trump says he won't extend Aug. 1 tariff deadline (Yahoo Finance)
02:18PM	Trump Says Hell Set 50% Copper Tariff, Wait Year on Drug Levies (Bloomberg)
02:17PM	Uber's highs, Trump tariff warning, Wendys CEO heads to Hershey (Yahoo Finance Video)
10:43AM	AstraZeneca Boasts Strong Oncology Portfolio: Can It Sustain Growth? (Zacks)
07:32AM	3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years (Motley Fool)
Jul-07-25 10:38AM	Top 5 Undervalued Dividend Stocks With Strong Payout Potential (MarketBeat)
Jul-05-25 06:30AM	The Best Dividend Stocks I'd Buy Right Now (Motley Fool)
07:45AM	Loading…
Jul-04-25 07:45AM	2 Stocks to Buy With Less Than $50 (Motley Fool)
06:28AM	HER2+ Breast Cancer Market Analysis and Forecasts Report 2025-2035 \| Emerging Markets and Players Shape Future of HER2-Positive Cancer Solutions (GlobeNewswire)
03:51AM	Prediction: 3 Magnificent Stocks That'll Be Worth More Than Palantir by 2028 (Motley Fool)
03:22AM	Pfizer Advances HYMPAVZI After Successful Hemophilia Trial Results (Insider Monkey)
Jul-03-25 08:30PM	Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons (Benzinga)
09:36AM	Robert F. Kennedy Jr. Just Did The Unexpected. He Helped Moderna. (Investor's Business Daily)
09:26AM	Will The Decline in Legacy Drugs Pull Down BMY's Top Line? (Zacks)
09:06AM	MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations (Zacks)
08:48AM	Pfizer Trades Above 50-Day Average for a Month: Time to Buy? (Zacks)
08:15AM	Activist investor Starboard Value discloses 9% stake in Tripadvisor (Reuters)
07:44AM	Regeneron nabs dosing edge with Lynozyfics FDA approval in multiple myeloma (Pharmaceutical Technology)
04:21AM	Is Pfizer Stock a Yield Trap? (Motley Fool)
03:51AM	3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 9% -- Which Make for No-Brainer Buys in July (Motley Fool)
Jul-02-25 05:45PM	Pfizer (PFE) Outperforms Broader Market: What You Need to Know (Zacks)
04:33PM	Kennedy Expands RSV Vaccine Recommendations. Moderna, Pfizer Shares Are Up. (Barrons.com)
01:30PM	Huge Unusual Volume in Pfizer Put Options Signals Investors Bullish Outlook (Barchart)
10:22AM	Analyst Report: Pfizer Inc. (Morningstar Research)
07:09AM	Pfizer terminates study of CD47 in blood cancer due to low recruitment (Clinical Trials Arena)
05:43AM	Semaglutide Market Forecast Report 2025-2033 \| Growth Accelerates Amid Rising Awareness, Regulatory Approvals, and Strong Pipeline Advancements (GlobeNewswire)
Jul-01-25 01:02PM	Improved Pharma initiates research and development program (PR Newswire)
11:06AM	Cannabis Lighting Market Report 2025-2030 \| Share Analysis, Industry Trends & Statistics, Growth Forecasts - Pfizer Ventures into Cannabis with $6.7 Billion Deal, Boosting Industry Growth (GlobeNewswire)
09:35AM	Pfizer's Strong Late-Stage Pipeline Can Drive Long-Term Growth (Zacks)
09:00AM	Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock (Zacks)
Jun-30-25 09:50AM	BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock? (Zacks)
Jun-29-25 09:28PM	XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations (PR Newswire)
Jun-28-25 06:35AM	3 No-Brainer Stocks to Buy for Under $100 Right Now (Motley Fool)
Jun-27-25 10:58AM	PFE's Hympavzi Phase III Hemophilia Study With Inhibitors Meets Goal (Zacks)
05:35AM	Pfizer reports positive results from Phase III BASIS trial for haemophilia (Clinical Trials Arena)
04:22AM	Sickle Cell Disease Treatment Market Analysis and Forecast, 2025-2035 \| Intensifying Competition as Key Players Advance Gene and Novel Therapies (GlobeNewswire)
Jun-26-25 12:00PM	All You Need to Know About Pfizer (PFE) Rating Upgrade to Buy (Zacks)
09:30AM	Smartlys Flagship Event ADVANCE Returns: New Voices, Big Ideas, and the Future of Marketing (Business Wire)
08:05AM	Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025 (Pharmaceutical Technology)
06:45AM	Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI in Hemophilia A or B with Inhibitors (Business Wire)
Jun-25-25 05:30PM	Pfizer Declares Third-Quarter 2025 Dividend (Business Wire)
10:02AM	Will New Drugs Enable BMY to Offset the Impact of Generic Competition? (Zacks)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts (Business Wire)
08:00AM	Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors (GlobeNewswire)
06:15AM	Alzheimers R&D resurgence driven by $16.8bn in acquisitions in 2025YTD (Pharmaceutical Technology)
12:03AM	3 Reasons PFE is Risky and 1 Stock to Buy Instead (StockStory)
Jun-24-25 05:45PM	Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
10:25AM	Pfizer to Face Several Headwinds: Can It Successfully Navigate Them? (Zacks)
08:22AM	Will AbbVie's Growing Oncology Portfolio Aid Top-line Growth? (Zacks)
07:10AM	My 5 Favorite Dirt Cheap Stocks to Buy Right Now (Motley Fool)
05:22AM	Kinase Inhibitors in Autoimmune Diseases Research Report 2025-2035 \| Market Accelerates Amid Rising Disease Prevalence, Kinase Innovation, and Demand for Safer Treatments (GlobeNewswire)
Jun-23-25 11:09PM	Pfizer's Dividend Backed by Strong Free Cash Flow (Insider Monkey)
12:48PM	Ireland Warns Thousands of Jobs at Risk From Pharma Tariffs (Bloomberg)
05:30AM	10 Stocks That Pay $100 or More in Dividends (Motley Fool)
12:09AM	The 5 Most Interesting Analyst Questions From Pfizer's Q1 Earnings Call (StockStory)
Jun-20-25 11:27AM	Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street. (Barrons.com)
10:01AM	Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now? (Zacks)
09:00AM	Is Trending Stock Pfizer Inc. (PFE) a Buy Now? (Zacks)
Jun-19-25 09:47AM	Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth? (Zacks)
03:00AM	Gene Therapy Has Lost Support on Wall Street. There's Still Hope for Big Cures. (Barrons.com)
Jun-18-25 10:00AM	Trump administration weighs crackdown on pharma ads, Bloomberg says (TipRanks)
07:00AM	2 Top Stocks to Buy With Less Than $30 (Motley Fool)
Jun-17-25 07:34PM	Analyst Report: Haleon plc (Morningstar Research)
05:16PM	Trump's big beautiful bill: What the pharma industry is watching (Yahoo Finance Video)
02:39PM	Slowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards? (Zacks)
11:20AM	Cantor Fitzgerald Maintains PFE At Neutral Amid Vaccine Guidance Changes and Regulatory Challenges (Insider Monkey)
11:18AM	AMD extends gains, solar stocks plummet, pharma stocks (Yahoo Finance Video)
10:32AM	Trump reportedly threatens pharma ads, disrupting $10B market (Yahoo Finance Video)
10:12AM	RFK Jr. Plans Crackdown on Pharma Ads in Threat to $10 Billion Market (Bloomberg)
09:40AM	Should Value Investors Buy Pfizer (PFE) Stock? (Zacks)
09:02AM	5 Low Price-to-Book Value Stocks That You Can Buy in June (Zacks)
04:49AM	Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock (Motley Fool)
Jun-16-25 11:40AM	PFE or LLY: Which Is the Better Value Stock Right Now? (Zacks)
11:20AM	EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy (Zacks)
09:29AM	4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil (Zacks)
09:06AM	5 Large Drug Stocks That Are Poised to Ride on Sector Recovery (Zacks)
09:00AM	Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE? (Zacks)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM

Dollar change -2.60
Percentage change -3.88	%

Peers: AN LAD PAG SAH ABG GPI TSLA GM F HOG

| Held by: VTI VOO VB VBR RSP SPY IVV XLY IWR EQTY

Index	S&P 500	P/E	17.79	EPS (ttm)	3.62	Insider Own	0.51%	Shs Outstand	150.58M	Perf Week	-8.88%
Market Cap	9.66B	Forward P/E	14.34	EPS next Y	4.49	Insider Trans	-2.93%	Shs Float	149.31M	Perf Month	-6.06%
Enterprise Value	28.30B	PEG	-	EPS next Q	1.04	Inst Own	108.80%	Short Float	9.62%	Perf Quarter	-19.64%
Income	558.50M	P/S	0.36	EPS this Y	21.20%	Inst Trans	-3.51%	Short Ratio	4.09	Perf Half Y	-18.68%
Sales	26.79B	P/B	1.54	EPS next Y	15.35%	ROA	2.04%	Short Interest	14.36M	Perf YTD	-21.31%
Book/sh	41.75	P/C	11.40	EPS next 5Y	-	ROE	8.97%	52W High	91.25 -29.49%	Perf Year	-10.96%
Cash/sh	5.64	P/FCF	17.85	EPS past 3/5Y	-22.80% -9.64%	ROIC	2.24%	52W Low	61.34 4.89%	Perf 3Y	-30.80%
Dividend Est.	-	EV/EBITDA	120.86	Sales past 3/5Y	-6.17% 5.34%	Gross Margin	10.17%	Volatility	2.49% 3.07%	Perf 5Y	-28.81%
Dividend TTM	-	EV/Sales	1.06	EPS Y/Y TTM	42.14%	Oper. Margin	-0.27%	ATR (14)	2.13	Perf 10Y	-3.49%
Dividend Ex-Date	-	Quick Ratio	0.80	Sales Y/Y TTM	3.17%	Profit Margin	2.08%	RSI (14)	41.14	Recom	2.10
Dividend Gr. 3/5Y	- -	Current Ratio	2.39	EPS Q/Q	42.62%	SMA20	-4.45%	Beta	1.37	Target Price	79.79
Payout	0.00%	Debt/Eq	3.10	Sales Q/Q	6.09%	SMA50	-3.23%	Rel Volume	0.86	Prev Close	66.94
Employees	30048	LT Debt/Eq	2.97	Earnings	Jun 20 BMO	SMA200	-14.30%	Avg Volume	3.51M	Price	64.34
IPO	Feb 04, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	18.84% 0.56%	Trades		Volume	3,029,976	Change	-3.88%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-01-25	Resumed	Morgan Stanley	Overweight	$80
May-19-25	Resumed	Wedbush	Outperform	$90
Mar-26-25	Upgrade	Stephens	Equal-Weight → Overweight	$86 → $90
Feb-06-25	Upgrade	Evercore ISI	In-line → Outperform	$90 → $110
Dec-05-24	Initiated	Stephens	Equal-Weight	$86
Mar-20-24	Upgrade	Needham	Hold → Buy	$99
Mar-19-24	Initiated	Mizuho	Neutral	$80
Sep-25-23	Upgrade	Wedbush	Neutral → Outperform	$85 → $90
Jun-12-23	Downgrade	Northcoast	Buy → Neutral
Feb-23-23	Resumed	Truist	Hold	$66
Jan-11-23	Downgrade	JP Morgan	Neutral → Underweight	$60
Jan-05-23	Downgrade	Argus	Buy → Hold
Dec-23-22	Reiterated	Oppenheimer	Outperform	$100 → $75
Oct-03-22	Downgrade	Stephens	Overweight → Equal-Weight	$105 → $64
Sep-09-22	Downgrade	BofA Securities	Neutral → Underperform	$146 → $100
May-02-22	Initiated	Needham	Hold
Apr-13-22	Downgrade	JP Morgan	Overweight → Neutral	$130 → $110
Apr-06-22	Downgrade	BofA Securities	Buy → Neutral	$195 → $165
Feb-16-22	Downgrade	Evercore ISI	Outperform → In-line	$120
Jan-28-22	Resumed	RBC Capital Mkts	Outperform	$157 → $140

Show Previous Ratings

Jul-11-25 09:04AM	Alphyn Capital Management Exited CarMax (KMX) as Share Price Stagnated (Insider Monkey)
Jul-10-25 01:58PM	CarMax, Inc. (KMX): A Bull Case Theory (Insider Monkey)
Jul-07-25 04:19PM	3 retail stock picks as Trump's trade deadline looms (Yahoo Finance Video)
10:12AM	5 Insightful Analyst Questions From CarMax's Q2 Earnings Call (StockStory)
09:37AM	Does Carvana's High Price-to-Sales Multiple Still Make Sense? (Zacks)
03:32AM	Loading…
Jul-04-25 03:32AM	RBC Maintains Outperform on CarMax, Raises Price Target After Strong Results (Insider Monkey)
Jul-03-25 01:00AM	It's July Fourth. Are You Ready for Yet Another American Revolution? (Barrons.com)
Jun-30-25 04:10PM	IBD Stock Of The Day Offers A Buy Opportunity Amid 120% Run Since April (Investor's Business Daily)
Jun-27-25 03:27PM	Analyst Report: CarMax, Inc. (Morningstar Research)
12:40AM	1 Safe-and-Steady Stock with Impressive Fundamentals and 2 to Turn Down (StockStory)
Jun-25-25 11:03AM	CarMax Stock: Is KMX Underperforming the Consumer Cyclical Sector? (Barchart)
10:21AM	From Ashes to Glory: Is Carvana's Premium Valuation Worth It? (Zacks)
05:05AM	Why CarMax stock is rising: The evolution of the American car buying experience (USA TODAY)
Jun-24-25 01:06PM	CarMax price target raised to $81 from $80 at RBC Capital (TipRanks)
08:00AM	Auto retail sector: Portfolio manager shares his top 2 picks (Yahoo Finance Video)
04:15PM	Loading…
Jun-23-25 04:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
09:28AM	Company News for Jun 23, 2025 (Zacks)
Jun-21-25 09:00AM	Morning Movers: GMS Inc. jumps after report of competing suitors (TipRanks)
08:45AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
03:00AM	CarMax Inc (KMX) Q1 2026 Earnings Call Highlights: Record Retail Gross Profit and Strong Sales ... (GuruFocus.com)
Jun-20-25 06:18PM	CarMax Stock Jumps After Tariffs Boost Used-Car Demand (GuruFocus.com) +6.59%
05:31PM	S&P 500 Gains and Losses Today: Kroger Stock Soars, Accenture Shares Drop (Investopedia)
04:56PM	Analyst Report: CarMax, Inc. (Morningstar Research)
03:20PM	Stocks to Watch Friday: Kroger, TSM, Accenture, GMS (The Wall Street Journal)
03:12PM	CarMax pops on Q1 earnings: The journey to catch up to Carvana (Yahoo Finance Video)
01:59PM	Stocks to Watch Friday: TSM, Accenture, Kroger, GMS (The Wall Street Journal)
01:40PM	'Halftime' Investment Committee Stocks on the Move: CarMax, Accenture and Rocket Companies (CNBC TV)
01:25PM	CarMax Stock Rises. Used-Car Retailer Races Past Earnings Expectations. (Barrons.com)
01:03PM	Why Is CarMax (KMX) Stock Rocketing Higher Today (StockStory)
11:55AM	Top Stock Movers Now: Kroger, CarMax, Accenture, and More (Investopedia)
11:50AM	Loading…
11:50AM	CarMax pops on strong Q1 results (CNBC TV)
11:46AM	CarMax's Q1 Sales Go Into Overdrive (Motley Fool)
11:41AM	CarMax among S&P's biggest gainers (MarketWatch)
11:19AM	CarMax Q1 Earnings Surpass Expectations, Revenues Increase Y/Y (Zacks)
10:55AM	CarMax Profit Rises as Tariff Worries Spur Used-Car Demand (The Wall Street Journal)
10:19AM	CarMax Profit Rises on Higher Revenue From Retail Used Vehicles (Investopedia)
09:30AM	CarMax (KMX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:00AM	CarMax (KMX) Q1 Earnings and Revenues Beat Estimates (Zacks)
07:45AM	GMS shares surge on possible bidding war and other early market movers (MarketWatch)
07:35AM	Carmax Posts Higher Profit, Revenue (The Wall Street Journal)
07:31AM	CarMax shares surge on strong Q1 earnings beat (Investing.com)
07:11AM	CarMax's (NYSE:KMX) Q2 Earnings Results: Revenue In Line With Expectations, Stock Soars (StockStory)
07:09AM	CarMax stock climbs on Q1 profit and revenue beat (MarketWatch)
07:04AM	CarMax Stock Climbs. Used-Car Retailer Races Past Earnings Expectations. (Barrons.com)
06:56AM	CarMax: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:50AM	CarMax Reports First Quarter Fiscal Year 2026 Results (Business Wire)
02:47AM	Stock Market Today: Dow, S&P 500 and Nasdaq futures flip higher after report Iran willing to discuss uranium enrichment limits (MarketWatch)
Jun-18-25 11:00PM	CarMax (KMX) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
07:00PM	TikTok, earnings, markets close for Juneteenth: What to Watch (Yahoo Finance Video)
08:31AM	5 Revealing Analyst Questions From CarMax's Q1 Earnings Call (StockStory)
Jun-16-25 09:15AM	Exploring Analyst Estimates for CarMax (KMX) Q1 Earnings, Beyond Revenue and EPS (Zacks)
Jun-15-25 02:00PM	Fed Interest Rate Decision, Economic Data, Lennar Earnings, and What Else to Watch This Week (Barrons.com)
07:32AM	Investors eye Middle East tensions and the Fed's 'dot plot': What to know this week (Yahoo Finance)
05:00AM	What To Expect in Markets This Week: Fed Rate Decision, Juneteenth Holiday, US Retail Sales, Tesla Robotaxi Rollout (Investopedia)
05:00AM	The Fed, Juneteenth, Accenture, CarMax: What to watch in the stock market this week (Quartz)
Jun-13-25 10:00AM	CarMax (KMX) Earnings Expected to Grow: Should You Buy? (Zacks)
Jun-11-25 08:15AM	Chewy (CHWY) Q1 Earnings and Revenues Surpass Estimates (Zacks)
Jun-09-25 09:40AM	Here's Why CarMax (KMX) is a Strong Value Stock (Zacks)
Jun-05-25 09:06AM	CarMax launches tools, resources to enhance used EV buying (TipRanks)
Jun-04-25 09:00AM	CarMax Announces Tools, Resources and Incentives to Enhance Used EV Buying Experience (GlobeNewswire)
May-29-25 06:05PM	CarMax Announces First Quarter Conference Call and Annual Meeting Information (Business Wire)
May-27-25 10:38AM	CarMax cruises into generative AI after revamping data infrastructure (CIO Dive)
May-26-25 12:38AM	3 of Wall Street's Favorite Stocks Facing Headwinds (StockStory)
May-23-25 02:01PM	Used Car Stocks CVNA, KMX and AN Positioned for Tariff Tailwinds (TipRanks)
12:00AM	CarMax (KMX): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
May-20-25 07:50AM	Carvanas (CVNA) Remarkable U-Turn Tempered by Macro Headwinds (TipRanks)
May-14-25 10:52AM	Are Options Traders Betting on a Big Move in CarMax Stock? (Zacks)
May-12-25 01:38PM	Used-Car Prices Jump On Tariffs, Lifting Carvana, These Other Auto-Retail Stocks (Investor's Business Daily)
May-08-25 01:00PM	CarMax Returns as Front-of-Jersey Sponsor for Richmond Ivy Soccer Club (GlobeNewswire)
May-07-25 02:16PM	Used car prices rise to the highest level since 2023 amid tariff concerns (Seeking Alpha)
May-06-25 10:22AM	Is CarMax, Inc. (KMX) Among the Best Car Stocks To Buy In 2025? (Insider Monkey)
May-05-25 08:48AM	Is CVNA Stock a Buy Pre-Q1 Earnings? Key Metrics to Watch (Zacks)
Apr-30-25 11:15AM	The Davenport Equity Opportunities Fund Q1 2025 Commentary (Seeking Alpha)
09:40AM	Why CarMax (KMX) is a Top Value Stock for the Long-Term (Zacks)
Apr-28-25 03:08AM	Camping World (CWH) Reports Q1: Everything You Need To Know Ahead Of Earnings (StockStory)
Apr-27-25 10:00AM	AutoNation: Resilient Earnings May Start To Crumble After Q1 (Seeking Alpha)
Apr-24-25 07:35AM	Giverny Capital Asset Management Q1 2025 Letter (Seeking Alpha)
Apr-23-25 10:28AM	Jim Cramer Holds on CarMax (KMX): "Don't Sell It Down Here - That's a Remarkable Decline" (Insider Monkey)
Apr-22-25 10:45PM	KMX Q1 Earnings: CarMax Matches Revenue Expectations, Misses Profit Targets Amid Shifting Market Dynamics (StockStory)
03:30PM	CarMax, Gotham FC Extend Mission-Driven Partnership, Driving Growth and Impact (GlobeNewswire)
09:30AM	From Trade-Ins to Top Picks: CarMax Reveals Used EV Shopping Trends (GlobeNewswire)
Apr-21-25 08:25PM	Lightning Round: Don't sell Carmax right now, says Jim Cramer (CNBC TV)
11:34AM	CVNA Stock Skyrockets 196% in a Year: Is it Still Worth Buying? (Zacks)
Apr-19-25 03:43AM	CarMax Stock Got Clobbered 17% in One Day. Is the Stock a Buy Now? (Motley Fool)
Apr-18-25 08:54AM	Giverny Capital Asset Management Sold Carmax (KMX) Amid Difficult Competitive Environment (Insider Monkey)
Apr-16-25 10:19AM	Tariffs, Trump, and Turmoil (Motley Fool) -5.34%
Apr-15-25 04:00AM	Bear of the Day: Cars.com (CARS) (Zacks)
12:19AM	Analyst Report: CarMax, Inc. (Morningstar Research)
Apr-14-25 10:38AM	CarMax, Inc. (KMX): "They Missed Bad… Nothing There," Says Jim Cramer (Insider Monkey)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Apr-13-25 07:15AM	CarMax Pulls Guidance: Shares Falling To Buyable Levels (MarketBeat)
Apr-12-25 07:50AM	What Moved Markets This Week (Seeking Alpha)
Apr-11-25 05:40PM	Tariffs May Have Mixed Effects On Carmax, May Boost Used Car Demand Due To Pricier New Cars: Analyst (Benzinga)
12:05PM	Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz (TipRanks)
11:38AM	Here's What Big Bank CEOs Are Saying About Tariffs and the Economy (Investopedia)
09:19AM	Company News for Apr 11, 2025 (Zacks)
07:39AM	CarMax pulls financial targets timeline amid whipsaw tariff concerns (Fortune)
05:46AM	Why CarMax Inc. (KMX) Went Down On Thursday? (Insider Monkey)
03:01AM	CarMax Inc (KMX) Q4 2025 Earnings Call Highlights: Record Profits and Strategic Growth Plans (GuruFocus.com)
Apr-10-25 11:31PM	Q4 2025 Carmax Inc Earnings Call (Thomson Reuters StreetEvents) -17.00%

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Daniels Jon G	EVP, CAF	Jul 02 '25	Sale	70.64	1,540	108,786	2,779	Jul 03 04:11 PM
JON DANIELS	Officer	Jul 02 '25	Proposed Sale	70.64	1,540	108,790		Jul 02 04:27 PM
STEENROD MITCHELL D	Director	Apr 24 '25	Buy	65.49	1,300	85,137	33,577	Apr 25 04:08 PM
Tuite Tyler	SVP & Chief Product Officer	Jan 28 '25	Option Exercise	78.61	4,869	382,752	5,096	Jan 30 04:15 PM
Tuite Tyler	SVP & Chief Product Officer	Jan 28 '25	Sale	84.58	4,869	411,820	227	Jan 30 04:15 PM
Tuite Tyler	Officer	Jan 28 '25	Proposed Sale	84.58	4,869	411,809		Jan 28 05:11 PM
Mayor-Mora Enrique N	EVP & CFO	Jan 15 '25	Option Exercise	63.04	5,000	315,200	25,260	Jan 17 04:41 PM
Mayor-Mora Enrique N	EVP & CFO	Jan 15 '25	Sale	81.43	5,000	407,150	20,260	Jan 17 04:41 PM
Livesay Jill A	VP, Controller & PAO	Jan 15 '25	Option Exercise	63.04	13,009	820,087	22,457	Jan 17 04:41 PM
Livesay Jill A	VP, Controller & PAO	Jan 15 '25	Sale	81.00	13,009	1,053,729	9,448	Jan 17 04:41 PM
Mayor-Mora Enrique N	Officer	Jan 15 '25	Proposed Sale	81.43	5,000	407,133		Jan 15 03:15 PM
Shamim Mohammad	EVP and CITO	Jan 08 '25	Option Exercise	63.04	12,845	809,749	24,583	Jan 10 04:42 PM
Shamim Mohammad	EVP and CITO	Jan 08 '25	Sale	81.94	12,845	1,052,519	11,738	Jan 10 04:42 PM
Shamim Mohammad	Officer	Jan 08 '25	Proposed Sale	81.94	12,845	1,052,472		Jan 08 04:37 PM
Lyski James	EVP, Chief Growth & Strat Off	Jan 02 '25	Option Exercise	63.04	57,986	3,655,437	80,789	Jan 03 04:13 PM
Lyski James	EVP, Chief Growth & Strat Off	Jan 02 '25	Sale	81.35	57,986	4,717,161	22,803	Jan 03 04:13 PM
Lyski James	Officer	Jan 02 '25	Proposed Sale	81.35	57,986	4,717,412		Jan 02 05:23 PM
Daniels Jon G	SVP, CAF	Dec 26 '24	Option Exercise	63.04	10,000	630,400	10,995	Dec 27 04:13 PM
Daniels Jon G	SVP, CAF	Dec 26 '24	Sale	85.30	10,000	853,000	995	Dec 27 04:13 PM
Shamim Mohammad	EVP and CITO	Dec 23 '24	Option Exercise	63.04	10,000	630,400	21,738	Dec 26 04:15 PM
Shamim Mohammad	EVP and CITO	Dec 23 '24	Sale	83.77	10,000	837,700	11,738	Dec 26 04:15 PM
Nash William D	President & CEO	Dec 23 '24	Option Exercise	63.04	120,513	7,597,140	302,196	Dec 26 04:15 PM
Nash William D	President & CEO	Dec 23 '24	Sale	83.24	120,513	10,030,953	181,683	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 24 '24	Option Exercise	63.04	30,245	1,906,645	31,240	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 23 '24	Option Exercise	63.04	7,600	479,104	8,595	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 24 '24	Sale	84.34	30,245	2,550,863	995	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 23 '24	Sale	84.00	7,600	638,400	995	Dec 26 04:15 PM
Daniels Jon G	Officer	Dec 26 '24	Proposed Sale	85.30	10,000	853,039		Dec 26 04:07 PM
Daniels Jon G	Officer	Dec 24 '24	Proposed Sale	85.00	15,000	1,275,000		Dec 26 12:22 PM
Daniels Jon G	Officer	Dec 23 '24	Proposed Sale	84.00	22,845	1,918,980		Dec 23 04:50 PM
Shamim Mohammad	Officer	Dec 23 '24	Proposed Sale	86.69	22,845	1,980,360		Dec 23 04:38 PM
Nash William D	Officer	Dec 23 '24	Proposed Sale	82.00	120,513	9,882,066		Dec 23 04:28 PM
Livesay Jill A	VP, Controller & PAO	Jul 29 '24	Option Exercise	63.04	12,000	756,480	21,448	Jul 30 04:20 PM
Livesay Jill A	VP, Controller & PAO	Jul 29 '24	Sale	83.52	12,000	1,002,240	9,448	Jul 30 04:20 PM
Shamim Mohammad	EVP and CITO	Jul 26 '24	Option Exercise	63.04	25,000	1,576,000	36,738	Jul 29 04:21 PM
Shamim Mohammad	EVP and CITO	Jul 26 '24	Sale	82.26	25,000	2,056,500	11,738	Jul 29 04:21 PM
Shamim Mohammad	Officer	Jul 26 '24	Proposed Sale	82.26	25,000	2,056,450		Jul 26 04:51 PM
Wilson Charles Joseph	EVP and COO	Jul 23 '24	Option Exercise	63.04	10,021	631,724	25,630	Jul 24 04:13 PM
Wilson Charles Joseph	EVP and COO	Jul 23 '24	Sale	80.02	10,021	801,880	15,609	Jul 24 04:13 PM
Mayor-Mora Enrique N	EVP & CFO	Jul 16 '24	Option Exercise	63.04	11,150	702,896	29,578	Jul 17 04:33 PM
Mayor-Mora Enrique N	EVP & CFO	Jul 16 '24	Sale	83.46	9,318	777,680	20,260	Jul 17 04:33 PM
Stuckey John M III	SVP, Gen Counsel & Secretary	Jul 15 '24	Option Exercise	63.04	19,673	1,240,186	20,642	Jul 16 04:13 PM
Stuckey John M III	SVP, Gen Counsel & Secretary	Jul 15 '24	Sale	82.01	19,673	1,613,383	969	Jul 16 04:13 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your FINVIZ experience